iShares US Pharmaceuticals ETF
177 hedge funds and large institutions have $550M invested in iShares US Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 61 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.58% more ownership
Funds ownership: 58.27% → 64.85% (+6.6%)
Holders
177
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$51.3M | |
| 2 | +$26.3M | |
| 3 | +$22.7M | |
| 4 |
ACM
Anfield Capital Management
Irvine,
California
|
+$9.41M |
| 5 |
JP Morgan Chase
New York
|
+$8.02M |
Top Sellers
| 1 | -$5.02M | |
| 2 | -$4.84M | |
| 3 | -$981K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$968K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$592K |
